Remicade Biosimilars Market is Estimated To Witness High Growth Owing To Growing Oncology Patient Base

Remicade Biosimilars Market


Remicade biosimilars are biologics drugs that are developed to be similar to an existing biologic drug (in this case infliximab, sold under the brand name Remicade) that is manufactured by a different company. Remicade biosimilars offer more treatment options for diseases like Crohn’s disease, ulcerative colitis, rheumatoid arthritis and other diseases treated with infliximab. They provide a more affordable alternative to the original biologic drug.

The Remicade Biosimilars Market is estimated to be valued at US$ 3,007.28 Mn in 2023 and is expected to exhibit a CAGR of 35.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Growing prevalence of inflammatory bowel disease (IBD) and other autoimmune disorders is a key factor driving the demand for biosimilar versions of Remicade. IBD incidence rates continue to rise globally, especially in developed nations. For instance, according to 2018 statistics provided by Crohn’s and Colitis Foundation, approximately 3 million Americans suffer from IBD. Biosimilar drugs offer a more cost-effective treatment solution to a growing patient pool. Furthermore, patent expiration of the originator drug Remicade and subsequent market entry of its biosimilars is boosting competitio

Porter’s Analysis
Threat of new entrants: Entry of new players remains challenging due to requirement of extensive R&D facilities, clinical trials, manufacturing facilities and distribution network. However, patent expiration creates opportunities.
Bargaining power of buyers: Large group purchasing organizations and presence of biosimilar options increase bargaining power of buyers.
Bargaining power of suppliers: Suppliers have moderate power due to presence of a few generic drug makers with specialized manufacturing capabilities.
Threat of new substitutes: Emergence of novel therapies for autoimmune diseases can divert market share. However, proven efficiency and safety of Remicade acts as barrier.
Competitive rivalry: Intense rivalry exists among large drug makers like Janssen and emerging biosimilar makers to gain market share.

SWOT Analysis
Strength: Established effectiveness and safety of Remicade for treating several autoimmune diseases. Large patient base of indicated conditions.
Weakness: High manufacturing costs and stringent regulatory barriers. Risk of drug-induced adverse effects and immunogenicity.
Opportunity: Patent expiration of Remicade provides opportunity for biosimilars. Increasing incidence of targeted diseases offers untapped growth prospects.
Threats: Entry of new treatment substitutes like anti-TNF drugs poses competitive threat. Pricing pressure from group purchasing organizations.

Key Takeaways

Global Remicade Biosimilars Market Demand is expected to witness high growth, exhibiting CAGR of 35% over the forecast period, due to increasing incidence rates of autoimmune diseases like rheumatoid arthritis, Crohn's disease etc. and rising demand for affordable biologics.

Regionally, North America dominated the global market in 2023 and is projected to maintain its lead over 2023-2030. This is attributed to growing prevalence of targeted diseases, favourable reimbursement scenario and early adoption of biosimilar drugs in the US. Meanwhile, Asia Pacific is poised to witness fastest growth during the forecast period due to increasing healthcare investments, large patient pool and patent expiration of Remicade providing scope for biosimilars in emerging countries.

Key players operating in the Remicade Biosimilars market are Janssen Biotech Inc., Merck &Co., Pfizer Inc. (AC. Hospira), Celltrion Inc., Alvogen, Napp Pharmaceuticals, and Nippon Kayaku. Major players are engaged in new product development and geographic expansion strategies to solidify their market position. 

Comments

Post a Comment

Popular posts from this blog

Ginseng Market Outlook, Analysis and forecast up to 2028

Image
  Ginseng Market Ginseng is a slow-growing perennial plant with green oval-shaped leaves and meaty roots that can persist for more than a century. Ginseng is classified into two types: American ginseng and Asian ginseng. Panax quinquefolius is the scientific name for American ginseng, whereas Panax ginseng is the scientific name for Asian ginseng. Ginseng is widely used as a herb to increase the body's energy levels. Ginseng's antioxidant and anti-inflammatory qualities serve to enhance the immune system, lowering the risk of viral and microbial infections. Ginseng also helps to lower the risk of diseases such as lung cancer, skin cancer, and liver cancer. Other health advantages of ginseng include lower blood sugar levels and improved cognitive functions such as memory and conduct. Ginseng is mostly grown in the United States, Canada, and South Korea. Ginseng has been used as a herbal medicine in China for generations, and the country is one of its largest users. Asia Pacifi
Read more

Forging has significant application in creation of various metal for wide range of applications

Image
Forging refers to any process that produces metal from scratch by subjecting it to an external force. Metal forgers can be persons or machines. This techniques may involve grinding (for example, to produce alloyed steel) or may involve the application of pressure to apply heat to the metal piece until it is malleable. The actual process depends on various factors, including the material being forged, its shape, and the degree of stress that is placed on it. Forged grain is the product of Forging with grains of metals pushed against each other through a forge-like tool and into the cladding that forms the final shape of the metal after it has been done. It is the principal production process in most metals. It uses local or repetitive thrusts delivered by a hammer or die to apply mechanical blows to the metal piece until it becomes malleable. It is frequently classified according to the speed at which it's done: fast, cold, or hot. There are many types of forgers available today
Read more

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19

Image
Germany Vaccine Contract Manufacturing industry is expected to witness significant growth in the near future, due to emergence of Covid-19. In Germany, from 3 January 2020 to 4:06pm CEST, 18 August 2021, there have been 3,835,375 confirmed cases of COVID-19 with 91,921 deaths, reported to WHO. As of 15 August 2021, a total of 97,884,043 vaccine doses have been administered. The increasing demand for safe and cost-effective vaccines due to unmatchable quality, consistent delivery, and unparalleled security, have contributed to the increasing growth and scope of this industry. The increasing demand for vaccines and resulting profit potential have led to significant growth in the number of contract manufacturing plants located across the world. A major focus of such plants is developing cost effective, high quality vaccines that could be made available to public health organizations and other medical organizations. Several new and innovative technologies are also being developed to man
Read more